{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:09:48Z","timestamp":1789477788447,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T00:00:00Z","timestamp":1611100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T00:00:00Z","timestamp":1611100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UH3DA044831"],"award-info":[{"award-number":["UH3DA044831"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s10461-020-03141-4","type":"journal-article","created":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T16:03:24Z","timestamp":1611158604000},"page":"1331-1339","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Harm Reduction and Adaptations Among PWUD in Rural Oregon During COVID-19"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8955-6210","authenticated-orcid":false,"given":"Andrew","family":"Seaman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Leichtling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Stack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Pope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica E.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith M.","family":"Leahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian","family":"Gelberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Todd","family":"Korthuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,20]]},"reference":[{"issue":"23","key":"3141_CR1","doi-asserted-by":"publisher","first-page":"12595","DOI":"10.1073\/pnas.2006706117","volume":"117","author":"EJ Raker","year":"2020","unstructured":"Raker EJ, Zacher M, Lowe SR. Lessons from Hurricane Katrina for predicting the indirect health consequences of the COVID-19 pandemic. Proc Natl Acad Sci USA. 2020;117(23):12595\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3141_CR2","unstructured":"Volkow N, NIDA. 2020. https:\/\/www.drugabuse.gov\/about-nida\/noras-blog\/2020\/04\/covid-19-potential-implications-individuals-substance-use-disorders."},{"key":"3141_CR3","first-page":"1","volume":"14","author":"QQ Wang","year":"2020","unstructured":"Wang QQ, Kaelber DC, Xu R, Volkow ND. COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States. Mol Psychiatry. 2020;14:1\u201310.","journal-title":"Mol Psychiatry."},{"issue":"16","key":"3141_CR4","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1001\/jama.2020.17477","volume":"324","author":"TA Ochalek","year":"2020","unstructured":"Ochalek TA, Cumpston KL, Wills BK, Gal TS, Moeller FG. Nonfatal opioid overdoses at an urban emergency department during the COVID-19 pandemic. JAMA. 2020;324(16):1673\u20134.","journal-title":"JAMA"},{"key":"3141_CR5","doi-asserted-by":"publisher","first-page":"108176","DOI":"10.1016\/j.drugalcdep.2020.108176","volume":"214","author":"S Slavova","year":"2020","unstructured":"Slavova S, Rock P, Bush HM, Quesinberry D, Walsh SL. Signal of increased opioid overdose during COVID-19 from emergency medical services data. Drug Alcohol Depend. 2020;214:108176.","journal-title":"Drug Alcohol Depend"},{"issue":"15","key":"3141_CR6","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1001\/jama.2020.17694","volume":"34","author":"J Wainwright","year":"2020","unstructured":"Wainwright J, Mikre M, Whitley P, Dawson E, Huskey A, Lukowiak A, et al. Analysis of drug test results before and after the US declaration of a national emergency concerning the COVID-19 outbreak. JAMA. 2020;34(15):1674\u20136.","journal-title":"JAMA"},{"issue":"6","key":"3141_CR7","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1007\/s11524-020-00484-0","volume":"97","author":"N Glober","year":"2020","unstructured":"Glober N, Mohler G, Huynh P, Arkins T, O\u2019Donnell D, Carter J, et al. Impact of COVID-19 Pandemic on drug overdoses in Indianapolis. J Urban Health. 2020;97(6):802\u20137.","journal-title":"J Urban Health"},{"issue":"6","key":"3141_CR8","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1007\/s11524-020-00486-y","volume":"97","author":"LN Rodda","year":"2020","unstructured":"Rodda LN, West KL, LeSaint KT. Opioid overdose-related emergency department visits and accidental deaths during the COVID-19 pandemic. J Urban Health. 2020;97(6):808\u201313.","journal-title":"J Urban Health"},{"issue":"2","key":"3141_CR9","first-page":"133","volume":"11","author":"A Farhoudian","year":"2020","unstructured":"Farhoudian A, Baldacchino A, Clark N, Gerra G, Ekhtiari H, Dom G, et al. COVID-19 and substance use disorders as brain diseases: recommendations to a comprehensive healthcare response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group Position Paper. Basic Clin Neurosci J. 2020;11(2):133\u201350.","journal-title":"Basic Clin Neurosci J"},{"issue":"6","key":"3141_CR10","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1111\/add.15080","volume":"115","author":"J Marsden","year":"2020","unstructured":"Marsden J, Darke S, Hall W, Hickman M, Holmes J, Humphreys K, et al. Mitigating and learning from the impact of COVID-19 infection on addictive disorders. Addiction. 2020;115(6):1007\u201310.","journal-title":"Addiction"},{"key":"3141_CR11","doi-asserted-by":"publisher","first-page":"108047","DOI":"10.1016\/j.drugalcdep.2020.108047","volume":"212","author":"AK Slaunwhite","year":"2020","unstructured":"Slaunwhite AK, Gan WQ, Xavier C, Zhao B, Buxton JA, Desai R. Overdose and risk factors for coronavirus disease 2019. Drug Alcohol Depend. 2020;212:108047.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"3141_CR12","doi-asserted-by":"publisher","first-page":"e200493","DOI":"10.1001\/jamanetworkopen.2020.0493","volume":"3","author":"WZ Akhtar","year":"2020","unstructured":"Akhtar WZ, Mundt MP, Koepke R, Krechel S, Fiore MC, Seal DW, et al. Prevalence of tobacco use among rural-dwelling individuals who inject drugs. JAMA Netw Open. 2020;3(3):e200493.","journal-title":"JAMA Netw Open"},{"issue":"20","key":"3141_CR13","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1001\/jama.2020.6775","volume":"323","author":"S Richardson","year":"2020","unstructured":"Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052\u20139.","journal-title":"JAMA"},{"issue":"3","key":"3141_CR14","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.amepre.2020.06.006","volume":"59","author":"IM Karaye","year":"2020","unstructured":"Karaye IM, Horney JA. The impact of social vulnerability on COVID-19 in the U.S.: an analysis of spatially varying relationships. Am J Prev Med. 2020;59(3):317\u201325.","journal-title":"Am J Prev Med."},{"key":"3141_CR15","doi-asserted-by":"crossref","unstructured":"Hunter A, Weekly ADA. Overdose resurgence amid pandemic fuels debate over treatment access measures. 2020;32(24):5\u20136.","DOI":"10.1002\/adaw.32750"},{"issue":"1","key":"3141_CR16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12954-020-00370-7","volume":"17","author":"A Dunlop","year":"2020","unstructured":"Dunlop A, Lokuge B, Masters D, Sequeira M, Saul P, Dunlop G, et al. Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic. Harm Reduct J. 2020;17(1):26.","journal-title":"Harm Reduct J"},{"issue":"48","key":"3141_CR17","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.15585\/mmwr.mm6448a3","volume":"64","author":"DC Des Jarlais","year":"2015","unstructured":"Des Jarlais DC, Nugent A, Solberg A, Feelemyer J, Mermin J, Holtzman D. Syringe service programs for persons who inject drugs in urban, suburban, and rural areas\u2014United States, 2013. Morb Mortal Wkly Rep. 2015;64(48):1337\u201341.","journal-title":"Morb Mortal Wkly Rep"},{"issue":"2\u20133","key":"3141_CR18","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.drugalcdep.2006.12.035","volume":"89","author":"RN Bluthenthal","year":"2007","unstructured":"Bluthenthal RN, Anderson R, Flynn NM, Kral AH. Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients. Drug Alcohol Depend. 2007;89(2\u20133):214\u201322.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"3141_CR19","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12889-017-4210-2","volume":"17","author":"RM Fernandes","year":"2017","unstructured":"Fernandes RM, Cary M, Duarte G, Jesus G, Alarcao J, Torre C, et al. Effectiveness of needle and syringe Programmes in people who inject drugs\u2014an overview of systematic reviews. BMC Public Health. 2017;17(1):309.","journal-title":"BMC Public Health"},{"issue":"2","key":"3141_CR20","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1057\/jphp.2014.54","volume":"36","author":"H Bramson","year":"2015","unstructured":"Bramson H, Des Jarlais DC, Arasteh K, Nugent A, Guardino V, Feelemyer J, et al. State laws, syringe exchange, and HIV among persons who inject drugs in the United States: history and effectiveness. J Public Health Policy. 2015;36(2):212\u201330.","journal-title":"J Public Health Policy"},{"key":"3141_CR21","first-page":"012021","volume":"9","author":"L Platt","year":"2017","unstructured":"Platt L, Minozzi S, Reed J, Vickerman P, Hagan H, French C, et al. Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs. Cochrane Database Syst Rev. 2017;9:012021.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"3141_CR22","doi-asserted-by":"publisher","first-page":"556","DOI":"10.15288\/jsad.2020.81.556","volume":"81","author":"M Bonn","year":"2020","unstructured":"Bonn M, Palayew A, Bartlett S, Brothers TD, Touesnard N, Tyndall M. Addressing the syndemic of HIV, hepatitis C, overdose, and COVID-19 among people who use drugs: the potential roles for decriminalization and safe supply. J Stud Alcohol Drugs. 2020;81(5):556\u201360.","journal-title":"J Stud Alcohol Drugs"},{"key":"3141_CR23","unstructured":"OHA sees 70% increase in Oregon opioid deaths during April, May [press release]. Oregon Health Authority. 2020."},{"key":"3141_CR24","unstructured":"Guidance about COVID-19 risk for harm reduction and syringe service programs [press release]. Public Health Acute and Communicable Disease Prevention. 2020."},{"issue":"9","key":"3141_CR25","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1007\/s10461-020-02886-2","volume":"24","author":"SN Glick","year":"2020","unstructured":"Glick SN, Prohaska SM, LaKosky PA, Juarez AM, Corcorran MA, Des Jarlais DC. The impact of COVID-19 on syringe services programs in the United States. AIDS Behav. 2020;24(9):2466\u20138.","journal-title":"AIDS Behav."},{"issue":"3","key":"3141_CR26","first-page":"2","volume":"2","author":"K Dombrowski","year":"2016","unstructured":"Dombrowski K, Crawford D, Bilal K, Kimberly T. Current rural drug use in the US Midwest. J Drug Abuse. 2016;2(3):2\u201314.","journal-title":"J Drug Abuse"},{"issue":"2","key":"3141_CR27","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/10550490601184159","volume":"16","author":"KM Grant","year":"2007","unstructured":"Grant KM, Kelley SS, Agrawal S, Meza JL, Meyer JR, Romberger DJ. Methamphetamine use in rural Midwesterners. Am J Addict. 2007;16(2):79\u201384.","journal-title":"Am J Addict"},{"issue":"SS-1","key":"3141_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss6601a1","volume":"66","author":"E Moy","year":"2017","unstructured":"Moy E, Garcia MC, Bastian B, Rossen LM, Ingram DD, Faul M, Massetti GM, Thomas CC, Hong Y, Yoon PW, Iademarco MF. Leading causes of death in Nonmetropolitan and Metropolitan areas\u2014United States, 1999\u20132014. MMWR Surveill Summ. 2017;66(SS-1):1\u20138.","journal-title":"MMWR Surveill Summ"},{"issue":"4","key":"3141_CR29","doi-asserted-by":"publisher","first-page":"716","DOI":"10.2105\/AJPH.2005.063255","volume":"96","author":"K Whetten","year":"2006","unstructured":"Whetten K, Leserman J, Whetten R, Ostermann J, Thielman N, Swartz M, et al. Exploring lack of trust in care providers and the government as a barrier to health service use. Am J Public Health. 2006;96(4):716\u201321.","journal-title":"Am J Public Health"},{"issue":"2","key":"3141_CR30","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/09595230500102434","volume":"24","author":"R Room","year":"2005","unstructured":"Room R. Stigma, social inequality and alcohol and drug use. Drug Alcohol Rev. 2005;24(2):143\u201355.","journal-title":"Drug Alcohol Rev"},{"issue":"12","key":"3141_CR31","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.drugpo.2015.06.006","volume":"26","author":"Y Soukup-Baljak","year":"2015","unstructured":"Soukup-Baljak Y, Greer AM, Amlani A, Sampson O, Buxton JA. Drug quality assessment practices and communication of drug alerts among people who use drugs. Int J Drug Policy. 2015;26(12):1251\u20137.","journal-title":"Int J Drug Policy"},{"key":"3141_CR32","unstructured":"WHO Director-General\u2019s opening remarks at the media briefing on COVID-19\u201411 March 2020 [press release]. World Health Organization 2020."},{"key":"3141_CR33","unstructured":"NIDA. 2020. https:\/\/www.drugabuse.gov\/news-events\/news-releases\/2017\/08\/grants-awarded-to-address-opioid-crisis-in-rural-regions."},{"key":"3141_CR34","unstructured":"International Q. NVivo Qualitative Data Analysis Software. https:\/\/qsrinternational.com\/nvivo\/nvivo-products\/. 1999."},{"key":"3141_CR35","volume-title":"Qualitative data analysis: a methods sourcebook","author":"M Miles","year":"2014","unstructured":"Miles M, Huberman A, Saldana J. Qualitative data analysis: a methods sourcebook. Thousand Oaks: Sage Publishing; 2014."},{"key":"3141_CR36","volume-title":"Applied thematic analysis","author":"G Guest","year":"2011","unstructured":"Guest G, MacQueen K, Namey E. Applied thematic analysis. Thousand Oaks, CA: Sage Publications, Incorporated; 2011."},{"issue":"4","key":"3141_CR37","doi-asserted-by":"publisher","first-page":"e0230811","DOI":"10.1371\/journal.pone.0230811","volume":"15","author":"A Bartal","year":"2020","unstructured":"Bartal A, Pliskin N, Tsur O. Local\/global contagion of viral\/non-viral information: analysis of contagion spread in online social networks. PLoS One. 2020;15(4):e0230811.","journal-title":"PLoS One"},{"key":"3141_CR38","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.1038\/srep04343","volume":"4","author":"NO Hodas","year":"2014","unstructured":"Hodas NO, Lerman K. The simple rules of social contagion. Sci Rep. 2014;4:4343.","journal-title":"Sci Rep"},{"issue":"9","key":"3141_CR39","doi-asserted-by":"publisher","first-page":"184148","DOI":"10.1371\/journal.pone.0184148","volume":"12","author":"B Monsted","year":"2017","unstructured":"Monsted B, Sapiezynski P, Ferrara E, Lehmann S. Evidence of complex contagion of information in social media: an experiment using Twitter bots. PLoS One. 2017;12(9):184148.","journal-title":"PLoS One"},{"key":"3141_CR40","unstructured":"United States COVID-19 Cases and Deaths by State. 2020. https:\/\/www.cdc.gov\/covid-data-tracker\/index.html#cases."}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-020-03141-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-020-03141-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-020-03141-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T15:14:05Z","timestamp":1618586045000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-020-03141-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,20]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["3141"],"URL":"https:\/\/doi.org\/10.1007\/s10461-020-03141-4","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,20]]},"assertion":[{"value":"15 December 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Andrew Seaman has received investigator-initiated research funding from Gilead Sciences and Merck & Co Pharmaceuticals unrelated to the content of this research. All other authors report no financial conflicts of interest. Dr. Korthuis serves as principal investigator for NIH-funded studies that accept donated study medications from Alkermes (extended-release naltrexone) and Indivior (buprenorphine).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The questionnaire, methodology, and study protocol for this study were approved by the Institutional Review Board of Oregon Health and Sciences University (IRB#:STUDY00020911).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Verbal informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication of quotes and summarized interview responses in the academic literature.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}